Project “Complexion” is a direct-to-consumer skincare platform specializing in products aimed at brightening skin and addressing issues such as dark spots, hyperpigmentation, acne scars, melasma, post-inflammatory hyperpigmentation (PIH), and uneven tone. Its product range features Korean-inspired active ingredients, including Arbutin, Tranexamic Acid, and Niacinamide. The company distinguishes itself with its clinically-formulated products, versatile creative strategies, and a growing base of subscribers, all supported by a proprietary DTC infrastructure. The supply chain of the company is designed for scalability and cross-border fulfillment without heavy reliance on owned warehouses or large-scale infrastructure. It sources its key skincare products from third-party suppliers, selling primarily through its direct-to-consumer platform. The company serves customers mainly in the U.S., U.K., Australia, Canada, and New Zealand, with the U.S. accounting for over 90% of sales. Orders are fulfilled via an international structure that reduces upfront capital requirements and fixed costs. The company employs a focused digital marketing strategy prioritized towards direct-response conversion and economic efficiency rather than just increasing traffic. The primary customer acquisition channel is Meta, focusing on messages about clinically-backed actives, transformation stories, testimonials, and educational content instead of generic lifestyle messaging. Financially, the company reported approximately $2.79 million in net revenue and $2.23 million in gross profit, equating to a gross margin of about 80%. It achieved a net profit of approximately $450K, with an annualized run-rate net income of around $1.57 million, showcasing robust product economics and efficient customer acquisition.